Lecture 5: Variations in Drug Responses in Special Populations Flashcards
what are the characteristics of the typical subject in a phase 1 clinical trial?
young (usually male) adult with no underlying disease conditions
changes in doses populations of different ages, weight, and organ function are typically made by ___
estimates
what is pharmacogenetics?
alteration of a single gene results in modified drug response
what is pharmacogenomics?
combination of multiple genetic differences across the genome resulting in varied responses to drugs
the largest source of variation in response to drugs in the adult population is due to ____ differences
genetic
there are genetic variations in many of the drug ___ enzymes
metabolizing
CYP2d^ is an example of an enzyme with ____ that result in cliniycallysignificant variations in response. This enzyme is responsible for the conversion of ___ to ___
genetic polymorphisms; codeine to morphine
t/f many genetic polymorphisms have beeb identified, but most don’t have clinically relevant results
true
____ metabolizers are most people and get the predicted effects of the drug
extensive (EM)
___metabolizers have less than the predicted effects in the case of a pro-drug such as codeine
poor (pm)
____ metabolizers have a greater than predicted effect in the case of pro-drugs such as codeine
ultra rapid (URM)
how can the issue of ultra-rapid metabolizers be corrected for mother’s breastfeeding?
choosing a different drug that does not have active metabolites
what is the function the OATP1B1 hepatic transporter?
facilitates entry on organic anions into hepatocytes for metabolism
what 2 genetic variations have been found in the OATP1b1 hepatic transporters?
- single amino acid changes that alter the function
2. reduced function phenotypes
how might a reduced OATP1B1 result in adverse reaction to simvastatin?
simvastatin has potential to cause muscle toxicity, and if the OATP1B1 has reduced function, there will be higher simvastatin concentration and more risk
the normal function of the OATP1B1 transporters are required for drug ___
metabolism and clearance
if a patient has reduced OATP1B1 function, should they be prescribed a lower or higher dose of statin?
lower
alteractions in the protein structure of the B2–AR influence ____ responses to regular ___ treatment
airway; bronchodilator
what is the single genetic change on the B2–AR receptor that influences the response to bronchodilators?
switch of Arg vs Glycolysis on codon 16
patients with the homozygous arginine on codon 16 of the B2–AR receptors experience what change in responsiveness to bronchodilators?
greater receptor desensitization and diminished responsiveness
patients with the homozygous glycine codon 16 of the B2–AR receptor experience what change in responsiveness to brocnhodilators?
less receptor desensitization and no change in responsiveness
neonates and infants have have ___ body water %
higher
premature babies have ___ body fat %
lower
elderly have ___ body water %
lower
elderly have ___ body fat %
higher
bioavailability of drugs ___ in class 3 obesity
increases
obesity
multifactorial disease that impacts many body systems, not simply a higher percentage of body fat
highly lipophilic drugs are expected to ___ Vd with higher adipose tissue in the body
increase
Obese patients often have ___ metabolism
unpredictable
many obese patients also suffer from hypertension, causing a ___ in renal excretion of drugs
decrease
it is important to consider drugs that cross the ___ in pregnant women
placenta
drugs that cause birth defects are called
teratogen
systems in what phase are most susceptible to teratogens?
developing
early in embryo development, teratogen exposure poses the highest overall risk to the development of ______ that may result in ___
anatomic abnormalities ; miscarriage